Skip to main content
Erschienen in: Abdominal Radiology 4/2013

01.08.2013

Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma

verfasst von: Hyun Jeong Park, Young Kon Kim, Min Jung Park, Won Jae Lee

Erschienen in: Abdominal Radiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the differential MRI features of small mass-forming intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC).

Methods

Sixty-four patients with pathologically proven small ICCs (n = 32) and HCCs (n = 32) (≤3.0 cm in diameter) who had undergone preoperative gadoxetic acid-enhanced MRI and DWI were enrolled in this study. Images were analyzed for the shape of the lesions, the presence of biliary dilatation, hyperenhancement (>50 % of the tumor volume) or rim enhancement on the arterial phase, capsular enhancement, and the presence of target appearance (a central enhancement with hypointense rim) on the hepatobiliary phase and on DWI (a central hypointense area with a peripheral hyperintense rim). Statistical significance of these findings was determined by the χ2 or Fisher’s exact test. Multivariate analysis was performed to identify independent imaging findings that allow differentiation of the two diseases.

Results

Univariate analysis revealed that the following significant parameters favor ICC over HCC: lobulating shape, rim enhancement on arterial phase, target appearance on the hepatobiliary phase, and DWI (P < 0.05). Multivariate logistic regression analysis revealed that only target appearance on the DWI was a significant and independent variable predictive of ICC, as 24 ICCs (75.0 %) and one HCC (3.1 %) showed this feature (P = 0.0003).

Conclusion

A target appearance on the DWI was the most reliable imaging feature for distinguishing small mass-forming ICC from small HCC.
Literatur
1.
Zurück zum Zitat Kham SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314CrossRef Kham SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314CrossRef
2.
Zurück zum Zitat Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357PubMedCrossRef Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357PubMedCrossRef
3.
Zurück zum Zitat Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125PubMedCrossRef Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125PubMedCrossRef
4.
Zurück zum Zitat Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827PubMedCrossRef Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827PubMedCrossRef
5.
Zurück zum Zitat Choi BI, Han JK, Shin YM, Baek SY, Han MC (1995) Peripheral cholangiocarcinoma: comparison of MRI with CT. Abdom Imaging 20:357–360PubMedCrossRef Choi BI, Han JK, Shin YM, Baek SY, Han MC (1995) Peripheral cholangiocarcinoma: comparison of MRI with CT. Abdom Imaging 20:357–360PubMedCrossRef
6.
Zurück zum Zitat Fan ZM, Yamashita Y, Harada M, et al. (1993) Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 161:313–317PubMedCrossRef Fan ZM, Yamashita Y, Harada M, et al. (1993) Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 161:313–317PubMedCrossRef
7.
Zurück zum Zitat Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158:77–79PubMedCrossRef Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158:77–79PubMedCrossRef
8.
Zurück zum Zitat Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176:1499–1507PubMedCrossRef Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176:1499–1507PubMedCrossRef
9.
Zurück zum Zitat Tani K, Kubota Y, Yamaguchi T, et al. (1991) MR imaging of peripheral cholangiocarcinoma. J Comput Assist Tomogr 15:975–978PubMedCrossRef Tani K, Kubota Y, Yamaguchi T, et al. (1991) MR imaging of peripheral cholangiocarcinoma. J Comput Assist Tomogr 15:975–978PubMedCrossRef
10.
Zurück zum Zitat Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21:59–65PubMedCrossRef Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21:59–65PubMedCrossRef
11.
Zurück zum Zitat Rimola J, Forner A, Reig M, et al. (2009) Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50:791–798PubMedCrossRef Rimola J, Forner A, Reig M, et al. (2009) Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50:791–798PubMedCrossRef
12.
Zurück zum Zitat Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020–2029PubMedCrossRef Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020–2029PubMedCrossRef
13.
Zurück zum Zitat Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern-correlation with clinicopathologic findings. Radiology 260:148–157PubMedCrossRef Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern-correlation with clinicopathologic findings. Radiology 260:148–157PubMedCrossRef
14.
Zurück zum Zitat Kim SJ, Lee JM, Han JK, et al. (2007) Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 189:1428–1434PubMedCrossRef Kim SJ, Lee JM, Han JK, et al. (2007) Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 189:1428–1434PubMedCrossRef
15.
Zurück zum Zitat El-Serag HB, Engels EA, Landgren O, et al. (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49:116–123PubMedCrossRef El-Serag HB, Engels EA, Landgren O, et al. (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49:116–123PubMedCrossRef
16.
Zurück zum Zitat Bruix J, Sherman M, American Association for the Study of Liver Disease (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1021PubMedCrossRef Bruix J, Sherman M, American Association for the Study of Liver Disease (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1021PubMedCrossRef
17.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef
18.
Zurück zum Zitat Kim YK, Kim CS, Han YM, Park G (2010) Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Invest Radiol 45:740–746PubMedCrossRef Kim YK, Kim CS, Han YM, Park G (2010) Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Invest Radiol 45:740–746PubMedCrossRef
19.
Zurück zum Zitat Kim SH, Kim SH, Lee J, et al. (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–1681PubMedCrossRef Kim SH, Kim SH, Lee J, et al. (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–1681PubMedCrossRef
20.
Zurück zum Zitat Kim YK, Kim CS, Han YM, et al. (2009) Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography. J Comput Assist Tomogr 33:844–850PubMedCrossRef Kim YK, Kim CS, Han YM, et al. (2009) Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography. J Comput Assist Tomogr 33:844–850PubMedCrossRef
21.
22.
Zurück zum Zitat Kim YK, Lee MW, Lee WJ, et al. (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤1.5 cm in diameter). Invest Radiol 47:159–166PubMed Kim YK, Lee MW, Lee WJ, et al. (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤1.5 cm in diameter). Invest Radiol 47:159–166PubMed
23.
Zurück zum Zitat Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedCrossRef Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedCrossRef
24.
Zurück zum Zitat Holland AE, Hecht EM, Hahn WY, et al. (2005) Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237:938–944PubMedCrossRef Holland AE, Hecht EM, Hahn WY, et al. (2005) Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237:938–944PubMedCrossRef
25.
Zurück zum Zitat Kim YK, Lee JM, Kim CS (2004) Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5–13PubMedCrossRef Kim YK, Lee JM, Kim CS (2004) Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5–13PubMedCrossRef
26.
Zurück zum Zitat Tamada T, Ito K, Sone T, et al. (2009) Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 29:636–640PubMedCrossRef Tamada T, Ito K, Sone T, et al. (2009) Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 29:636–640PubMedCrossRef
27.
Zurück zum Zitat Gabata T, Matsui O, Kadoya M, et al. (1998) Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 23:309–313PubMedCrossRef Gabata T, Matsui O, Kadoya M, et al. (1998) Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 23:309–313PubMedCrossRef
28.
Zurück zum Zitat Kim YK, Han YM, Kim CS (2009) Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol 70:94–100PubMedCrossRef Kim YK, Han YM, Kim CS (2009) Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol 70:94–100PubMedCrossRef
Metadaten
Titel
Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma
verfasst von
Hyun Jeong Park
Young Kon Kim
Min Jung Park
Won Jae Lee
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 4/2013
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9943-x

Weitere Artikel der Ausgabe 4/2013

Abdominal Radiology 4/2013 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.